Resolor (prucalopride) / J&J, Takeda 
Welcome,         Profile    Billing    Logout  

25 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Resolor (prucalopride) / J&J, Takeda
2010-023996-25: The effect of fluoxetine and 5-HT4 serotonin receptor agonists on cerebral axonal energy metabolism and glutamate levels in multiple sclerosis.

Ongoing
4
32
Europe
fluoxetine, Cisapride, Prucalopride, Coated tablet
Multiple sclerosis (both relapsing remitting and progressive forms)
 
 
2012-004367-44: A STUDY TO COMPARE THE EFFECT OF A STIMULANT LAXATIVE (SODIUM PICOSULFATE) AND OF A PROKINETIC DRUG (PRUCALOPRIDE) ON SENSITIVITY AND MOTILITY OF THE LEFT COLON IN HEALTHY SUBJECTS

Ongoing
4
10
Europe
SODIUM PICOSULFATE, PRUCALOPRIDE, Tablet, Coated tablet, GUTTALAX, RESOLOR
KU LEUVEN, KULEUVEN
SENSORY AND MOTOR RESPONSE OF DESCENDING COLON TO DISTENSION WILL BE STUDIED IN HEALTHY SUBJECTS, HEALTHY SUBJECTS, Body processes [G] - Physiological processes [G07]
 
 
2013-002705-65: The effect of Prucalopride (Resolor) on the stomach motor function and the stomach sensitivity

Ongoing
4
20
Europe
Resolor
TARGID, TARGID, KULeuven
Functional dyspepsia, Functional dyspepsia is a medical condition characterized by chronic or recurrent pain in the upper abdomen, upper abdominal fullness and feeling full earlier than expected when eating., Diseases [C] - Digestive System Diseases [C06]
 
 
2014-000361-52: Pilot study: Anti-inflammatory effect of stimulation of the intestinal nervous system: a potential new therapy to accelerate gastric emptying

Ongoing
4
30
Europe
Resolor, M0001, Film-coated tablet, Resolor
KULeuven, KULeuven
Patients undergoing pancreaduodenectomy due to benign or malignant tumor drug will be studied for prokinetic or anti-inflammatory effects, because they are known to influence gastrointestinal motility, Patients undergoing partial or full resection of the pancreas due to benign or malignant tumor, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
2013-000821-30: CLINICAL RESPONSE TO 5HT4 RECEPTORS AGONIST (PRUCALOPRIDE): GASTROCOLIC REFLEX ESTUDIO DEL REFLEJO GASTROCOLICO: INFLUENCIA DE PRUCALOPRIDA

Ongoing
4
10
Europe
Resolor, Resolor
Enrique Rey Díaz-Rubio, fundacion investigación biomedica hospital clinico san carlos
chronic constipation estreñimiento cronico
 
 
2012-005348-92: PROGASS PRucalopride On the GAstreonteric transit in Systemic Sclerosis PROGASS Studio per valutare l’effetto gastroenterico della Prucalopride in pazienti affetti da sclerosi sistemica

Ongoing
4
40
Europe
RESOLOR*28CPR RIV 2MG, RESOLOR*28CPR RIV 2MG
FONDAZIONE IRCCS CA\' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO, Shire Italia S.p.A
Sysemic sclerosis with gastroenteric involvement (constipation) Sclerosi sistemica con interessamento gastroenterico (stipsi)
 
 
2017-004175-31: A study to investigate the efficacy of prucalopride to treat typical reflux symptoms in patients with gastro-esophageal reflux disease Een studie om de efficaciteit van prucalopride in de behandeling van reflux symptomen in patiënten met gastro-oesofageale reflux ziekte.

Ongoing
4
60
Europe
Resolor, Coated tablet, Resolor 2mg
TARGID, KU Leuven, TARGID, KU Leuven
refractory gastro-esophageal reflux disease refractaire gastro-oesofagale reflux ziekte, refractory gastro-oesophageal reflux disease refractaire gastro-oesofagale reflux ziekte, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
NCT04985669: Study of Comparative Effectiveness of Prucalopride and Lubiprostone in Constipation Predominant Irritable Bowel Syndrome

Recruiting
4
140
RoW
Prucalopride 2mg, calopride
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Patient Satisfaction
02/22
03/22
NCT02425774: Anti-inflammatory Effect of Pre-operative Stimulation of the Cholinergic Anti-Inflammatory Pathway

Recruiting
4
30
Europe
Vagus stimulation, Sham stimulation, Prucalopride, Placebo
KU Leuven, Universitaire Ziekenhuizen KU Leuven
Postoperative Ileus
12/25
12/25
NCT05455359: Gastrointestinal Dysmotility on Aspiration Risk

Not yet recruiting
4
120
NA
Prucalopride, Famotidine
Boston Children's Hospital
Esophageal Motility Disorders, Gastric Motor Dysfunction, Aspiration Pneumonia, Gastro Esophageal Reflux
07/27
07/27
NCT05726097: Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure

Completed
3
147
Europe
polyethylene glycol, Laxabon, sodium phosphate, Phosphoral, polyethylene glycol + ascorbic acid, Plenvu, gastrografin, magnesiumoxid + sodium picosulfate, Picoprep, prucalopride, Resolol
Region Skane, Lund University, Odense University Hospital
Colon Cancer, Inflammatory Bowel Diseases, Gastrointestinal Bleed, Colon Polyp
10/23
10/23
2022-003221-22: A study to determine how safe and effective different doses of prucalopride are in children and teenagers with functional constipation

Not yet recruiting
3
175
US
Prucalopride, TAK-555, Film-coated tablet, Oral solution
Takeda Development Center Americas, Inc., Takeda Development Center Americas, Inc.
Constipation, Constipation, Diseases [C] - Digestive System Diseases [C06]
 
 
NCT04759833: A Study of Prucalopride For Functional Constipation in Children and Teenagers

Terminated
3
175
US
Prucalopride, TAK-555, Prucalopride succinate, Placebo
Takeda, Takeda Development Center Americas, Inc.
Constipation
11/23
11/23
NCT04757493: The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome

Recruiting
2/3
160
RoW
Prucalopride 2mg, Placebo
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Irritable Bowel Syndrome
10/21
11/21
2011-000308-16: Prucalopride versus placebo in patients with significantly delayed gastric emptying of idiopathic and diabetic nature

Ongoing
2
60
Europe
Film-coated tablet, Resolor
UZ Leuven, Shire
Patients with delayed gastric emptying (t1/2 for solids ≥ 109 min) either from idiopathic or diabetic origin, delayed gastric emptying (when it takes ≥ 109 minutes before half of a standard solid meal has left the stomach) either from idiopathic or diabetic origin, Diseases [C] - Digestive System Diseases [C06]
 
 
2018-002192-18: Characterization of a macrophage population under the control of nerves in the gastrointestinal tract Karakterisatie van de macrofaagpopulatie die onder de controle is van zenuwcellen in het maagdarmstelsel

Ongoing
2
10
Europe
Resolor, Film-coated tablet, Resolor
KU Leuven, KU Leuven
Patients undergoing colorectal surgery due to benign or malignant carcinoma, diverticulitis or constipationdrug will be used to differentiate between macrophages that are modulated by enteric neurons and those that are not, Patients undergoing partial or full resection of the colon or rectum, Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]
 
 
NCT05001763: Prucalopride for Postoperative Ileus in Patients Undergoing Robot-assisted Laparoscopic Radical Cystectomy

Not yet recruiting
2
160
NA
Prucalopride, Resolor, Placebo
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Postoperative Ileus, Bladder Cancer
09/23
10/23
ChiCTR1800016158: Role of prucalopride and its effectiveness in bowel preparation for colonoscopy

Completed
N/A
189
 
Prucalopride ;Fleet
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
People who receive colonoscopy
 
 
ChiCTR-IPR-17011999: The Application of Lactulose and Prucalopride in Intestine Preparation in Chronic Constipation Patients before Colonoscopy

Not yet recruiting
N/A
100
 
Polyethylene glycol ;Polyethylene glycol + Lactulose
Jingjiang People Hospital; None, Independent Project
the cleansing of bowel
 
 
ChiCTR-INR-17010922: Treatment of Slow Transit Constipation in elders with Zhizhu Pills

Not yet recruiting
N/A
100
 
ZhiShi 10g, BaiZhu 30g ;ZhiShi 10g, BaiZhu 50g ;ZhiShi 10g, BaiZhu 70g ;Prucalopride Succinate Tablets
The Affiliated Hospital of Nanjing University of Chinese Medicine; The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Provincial Commission of Health and Family Planning
Constipation
 
 
PROGRESS, NCT05220228: Prucalopride and Cognition in Recovered Depression

Completed
N/A
50
Europe
Prucalopride, Resolor, Montegrity, Axunio, Placebo
University of Oxford
Depression in Remission
11/23
11/23
NCT05966246: The Effect of Prucalopride Succinate on Gastrointestinal Motility After Laparoscopic Gastrectomy : Prospective Double Blind Case-control Study

Completed
N/A
106
RoW
Arm I : Experimental (Prucalopride succinate group), Arm II : Control (Mosapride citrate group)
Gangnam Severance Hospital
Gastric Cancer
06/23
06/23
NCT04961840: A Study to Assess Maternal and Fetal Outcomes After Taking Prucalopride During Pregnancy

Active, not recruiting
N/A
100
US
No Intervention
Takeda
Constipation, Pregnancy
12/25
12/25
NCT04869280: Post-Marketing Study of Prucalopride Safety In Pregnancy

Recruiting
N/A
616
US
No Intervention
Takeda, The Organization of Teratology Information Specialists
Chronic Constipation
05/26
05/26
NCT04838522: A Study of Prucalopride in Breastfeeding Women With Constipation

Recruiting
N/A
12
US
No Intervention
Takeda, UC San Diego Human Milk Research Biorepository
Chronic Constipation
12/26
12/26

Download Options